[
  {
    "ts": null,
    "headline": "Ashley Snyder Joins Medical Home Network as Chief Development Officer to Lead Partnership Efforts",
    "summary": "Medical Home Network (MHN), a mission-driven organization enabling federally qualified health centers (FQHCs) nationwide to succeed in value-based care, today announced the appointment of Ashley Snyder as its first Chief Development Officer.",
    "url": "https://finnhub.io/api/news?id=a7ca6221c746dfb4757ee8f252b1b28cb659329fb426df8d96fc394b69445401",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753279380,
      "headline": "Ashley Snyder Joins Medical Home Network as Chief Development Officer to Lead Partnership Efforts",
      "id": 136044835,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "Medical Home Network (MHN), a mission-driven organization enabling federally qualified health centers (FQHCs) nationwide to succeed in value-based care, today announced the appointment of Ashley Snyder as its first Chief Development Officer.",
      "url": "https://finnhub.io/api/news?id=a7ca6221c746dfb4757ee8f252b1b28cb659329fb426df8d96fc394b69445401"
    }
  },
  {
    "ts": null,
    "headline": "Universal Health to Report Q2 Earnings: What Do the Key Estimates Say?",
    "summary": "UHS' Q2 results are likely to reflect gains from hospital and behavioral health services. However, rising costs may cloud earnings upside.",
    "url": "https://finnhub.io/api/news?id=cadfc75986abaef79bae650c5534eed512618dd92665950f27b42777496fd79f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753279260,
      "headline": "Universal Health to Report Q2 Earnings: What Do the Key Estimates Say?",
      "id": 136062793,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "UHS' Q2 results are likely to reflect gains from hospital and behavioral health services. However, rising costs may cloud earnings upside.",
      "url": "https://finnhub.io/api/news?id=cadfc75986abaef79bae650c5534eed512618dd92665950f27b42777496fd79f"
    }
  },
  {
    "ts": null,
    "headline": "Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings",
    "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
    "url": "https://finnhub.io/api/news?id=0385fc48f12a46ed5d67d7856a2a298953c22915f747c84e9b6602edbae95857",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753275602,
      "headline": "Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings",
      "id": 136063178,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
      "url": "https://finnhub.io/api/news?id=0385fc48f12a46ed5d67d7856a2a298953c22915f747c84e9b6602edbae95857"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons to Avoid DVA and 1 Stock to Buy Instead",
    "summary": "Over the past six months, DaVita’s shares (currently trading at $146.05) have posted a disappointing 14% loss, well below the S&P 500’s 3.1% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.",
    "url": "https://finnhub.io/api/news?id=8e7b5349d9f152f8181ae035bdd77f6ced7f1738eb85791bd030bfa4342ea761",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753243588,
      "headline": "3 Reasons to Avoid DVA and 1 Stock to Buy Instead",
      "id": 136039802,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "Over the past six months, DaVita’s shares (currently trading at $146.05) have posted a disappointing 14% loss, well below the S&P 500’s 3.1% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.",
      "url": "https://finnhub.io/api/news?id=8e7b5349d9f152f8181ae035bdd77f6ced7f1738eb85791bd030bfa4342ea761"
    }
  }
]